Peroxidase activity of hemoglobin towards ascorbate and urate: A synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC)

Acellular hemoglobins developed as oxygen bridging agents with volume expanding properties (“blood substitutes”) are prone to autoxidation and oxidant-mediated structural changes in circulation. In the presence of hydrogen peroxide and either ascorbate or urate we show that ferric hemoglobin functio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochimica et biophysica acta 2008-10, Vol.1784 (10), p.1415-1420
Hauptverfasser: Cooper, Chris E., Silaghi-Dumitrescu, Radu, Rukengwa, Martine, Alayash, Abdu I., Buehler, Paul W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1420
container_issue 10
container_start_page 1415
container_title Biochimica et biophysica acta
container_volume 1784
creator Cooper, Chris E.
Silaghi-Dumitrescu, Radu
Rukengwa, Martine
Alayash, Abdu I.
Buehler, Paul W.
description Acellular hemoglobins developed as oxygen bridging agents with volume expanding properties (“blood substitutes”) are prone to autoxidation and oxidant-mediated structural changes in circulation. In the presence of hydrogen peroxide and either ascorbate or urate we show that ferric hemoglobin functions as a true enzymatic peroxidase. The activity saturates with both substrates and is linearly dependent on protein concentration. The activity is enhanced at low pH with a p K a of 4.7, consistent with protonation of the ferryl species (Fe(IV)−OH) as the active intermediate. To test whether these redox reactions define its behaviour in vivo we exchanged transfused guinea pigs with 50% polymerized bovine Hb (PolyHbBv) and monitored plasma levels of endogenous ascorbate and urate. Immediately after transfusion, met PolyHbBv levels increased up to 30% of total Hb and remained at this level during the first 24 h post transfusion. Plasma ascorbate decreased by 50% whereas urate levels remained unchanged after transfusion. A simple kinetic model, assuming that ascorbate was a more active ferric heme reductase and peroxidase substrate than urate, was consistent with the in vivo data. The present finding confirms the primary and secondary roles of ascorbate and urate respectively in maintaining the oxidative stability of infused Hb.
doi_str_mv 10.1016/j.bbapap.2008.03.019
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745714533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1570963908001039</els_id><sourcerecordid>745714533</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-715e4c1d251be0eaae2ebacda25fdf473fed3c6db717db1f517db4b5cbddf1ee3</originalsourceid><addsrcrecordid>eNp9kUFvEzEQhS1UREvhH1TIt8JhF3t3HW84ILUREKRK6QHO1tie3TpK1sF2Qva_8GPrVSK4cZo5fPOe_R4hN5yVnPHZx3WpNexgV1aMtSWrS8bnL8gVb2Vb8EY0F3kXkhXzWT2_JK9jXDNWMSnFK3LJ20bIWcuvyJ9HDP7oLESkYJI7uDRS39En3Pp-47UbaPK_IdhIIRofNKQMDpbuQ94-0TsaxwFD72Jyhu6CTzipII1pAvqRQg9uiCnLHJ05qy__qhf32dnS1XHscaALCMFhiPT98n61-PCGvOxgE_HteV6Tn1-__Fgsi4fVt--Lu4fCNKJNheQCG8NtJbhGhgBYoQZjoRKd7RpZd2hrM7Nacmk178Q0Gi2MtrbjiPU1uT3p5vf_2mNMauuiwc0GBvT7qGROK0da15lsTqQJPsaAndoFt4UwKs7UVItaq1MtaqpFsVrlWvLZu7PBXm_R_js695CBzycA8zcPOQIVjcPBoHUhB6qsd_93eAY3N6We</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>745714533</pqid></control><display><type>article</type><title>Peroxidase activity of hemoglobin towards ascorbate and urate: A synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Cooper, Chris E. ; Silaghi-Dumitrescu, Radu ; Rukengwa, Martine ; Alayash, Abdu I. ; Buehler, Paul W.</creator><creatorcontrib>Cooper, Chris E. ; Silaghi-Dumitrescu, Radu ; Rukengwa, Martine ; Alayash, Abdu I. ; Buehler, Paul W.</creatorcontrib><description>Acellular hemoglobins developed as oxygen bridging agents with volume expanding properties (“blood substitutes”) are prone to autoxidation and oxidant-mediated structural changes in circulation. In the presence of hydrogen peroxide and either ascorbate or urate we show that ferric hemoglobin functions as a true enzymatic peroxidase. The activity saturates with both substrates and is linearly dependent on protein concentration. The activity is enhanced at low pH with a p K a of 4.7, consistent with protonation of the ferryl species (Fe(IV)−OH) as the active intermediate. To test whether these redox reactions define its behaviour in vivo we exchanged transfused guinea pigs with 50% polymerized bovine Hb (PolyHbBv) and monitored plasma levels of endogenous ascorbate and urate. Immediately after transfusion, met PolyHbBv levels increased up to 30% of total Hb and remained at this level during the first 24 h post transfusion. Plasma ascorbate decreased by 50% whereas urate levels remained unchanged after transfusion. A simple kinetic model, assuming that ascorbate was a more active ferric heme reductase and peroxidase substrate than urate, was consistent with the in vivo data. The present finding confirms the primary and secondary roles of ascorbate and urate respectively in maintaining the oxidative stability of infused Hb.</description><identifier>ISSN: 1570-9639</identifier><identifier>ISSN: 0006-3002</identifier><identifier>EISSN: 1878-1454</identifier><identifier>DOI: 10.1016/j.bbapap.2008.03.019</identifier><identifier>PMID: 18457681</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Ascorbate ; Ascorbic Acid - blood ; Ascorbic Acid - pharmacology ; Blood substitute ; Blood Substitutes - therapeutic use ; Blood Substitutes - toxicity ; Buffers ; Drug Carriers - toxicity ; Ferric Compounds ; Ferryl ; Guinea Pigs ; Hemoglobin ; Hemoglobins - metabolism ; Hemoglobins - toxicity ; Humans ; Kinetics ; Oxygen - blood ; Oxygen - metabolism ; Oxyhemoglobins - therapeutic use ; Peroxidase ; Peroxidases - blood ; Urate ; Uric Acid - blood</subject><ispartof>Biochimica et biophysica acta, 2008-10, Vol.1784 (10), p.1415-1420</ispartof><rights>2008 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-715e4c1d251be0eaae2ebacda25fdf473fed3c6db717db1f517db4b5cbddf1ee3</citedby><cites>FETCH-LOGICAL-c458t-715e4c1d251be0eaae2ebacda25fdf473fed3c6db717db1f517db4b5cbddf1ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1570963908001039$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18457681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cooper, Chris E.</creatorcontrib><creatorcontrib>Silaghi-Dumitrescu, Radu</creatorcontrib><creatorcontrib>Rukengwa, Martine</creatorcontrib><creatorcontrib>Alayash, Abdu I.</creatorcontrib><creatorcontrib>Buehler, Paul W.</creatorcontrib><title>Peroxidase activity of hemoglobin towards ascorbate and urate: A synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC)</title><title>Biochimica et biophysica acta</title><addtitle>Biochim Biophys Acta</addtitle><description>Acellular hemoglobins developed as oxygen bridging agents with volume expanding properties (“blood substitutes”) are prone to autoxidation and oxidant-mediated structural changes in circulation. In the presence of hydrogen peroxide and either ascorbate or urate we show that ferric hemoglobin functions as a true enzymatic peroxidase. The activity saturates with both substrates and is linearly dependent on protein concentration. The activity is enhanced at low pH with a p K a of 4.7, consistent with protonation of the ferryl species (Fe(IV)−OH) as the active intermediate. To test whether these redox reactions define its behaviour in vivo we exchanged transfused guinea pigs with 50% polymerized bovine Hb (PolyHbBv) and monitored plasma levels of endogenous ascorbate and urate. Immediately after transfusion, met PolyHbBv levels increased up to 30% of total Hb and remained at this level during the first 24 h post transfusion. Plasma ascorbate decreased by 50% whereas urate levels remained unchanged after transfusion. A simple kinetic model, assuming that ascorbate was a more active ferric heme reductase and peroxidase substrate than urate, was consistent with the in vivo data. The present finding confirms the primary and secondary roles of ascorbate and urate respectively in maintaining the oxidative stability of infused Hb.</description><subject>Animals</subject><subject>Ascorbate</subject><subject>Ascorbic Acid - blood</subject><subject>Ascorbic Acid - pharmacology</subject><subject>Blood substitute</subject><subject>Blood Substitutes - therapeutic use</subject><subject>Blood Substitutes - toxicity</subject><subject>Buffers</subject><subject>Drug Carriers - toxicity</subject><subject>Ferric Compounds</subject><subject>Ferryl</subject><subject>Guinea Pigs</subject><subject>Hemoglobin</subject><subject>Hemoglobins - metabolism</subject><subject>Hemoglobins - toxicity</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Oxygen - blood</subject><subject>Oxygen - metabolism</subject><subject>Oxyhemoglobins - therapeutic use</subject><subject>Peroxidase</subject><subject>Peroxidases - blood</subject><subject>Urate</subject><subject>Uric Acid - blood</subject><issn>1570-9639</issn><issn>0006-3002</issn><issn>1878-1454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFvEzEQhS1UREvhH1TIt8JhF3t3HW84ILUREKRK6QHO1tie3TpK1sF2Qva_8GPrVSK4cZo5fPOe_R4hN5yVnPHZx3WpNexgV1aMtSWrS8bnL8gVb2Vb8EY0F3kXkhXzWT2_JK9jXDNWMSnFK3LJ20bIWcuvyJ9HDP7oLESkYJI7uDRS39En3Pp-47UbaPK_IdhIIRofNKQMDpbuQ94-0TsaxwFD72Jyhu6CTzipII1pAvqRQg9uiCnLHJ05qy__qhf32dnS1XHscaALCMFhiPT98n61-PCGvOxgE_HteV6Tn1-__Fgsi4fVt--Lu4fCNKJNheQCG8NtJbhGhgBYoQZjoRKd7RpZd2hrM7Nacmk178Q0Gi2MtrbjiPU1uT3p5vf_2mNMauuiwc0GBvT7qGROK0da15lsTqQJPsaAndoFt4UwKs7UVItaq1MtaqpFsVrlWvLZu7PBXm_R_js695CBzycA8zcPOQIVjcPBoHUhB6qsd_93eAY3N6We</recordid><startdate>20081001</startdate><enddate>20081001</enddate><creator>Cooper, Chris E.</creator><creator>Silaghi-Dumitrescu, Radu</creator><creator>Rukengwa, Martine</creator><creator>Alayash, Abdu I.</creator><creator>Buehler, Paul W.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20081001</creationdate><title>Peroxidase activity of hemoglobin towards ascorbate and urate: A synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC)</title><author>Cooper, Chris E. ; Silaghi-Dumitrescu, Radu ; Rukengwa, Martine ; Alayash, Abdu I. ; Buehler, Paul W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-715e4c1d251be0eaae2ebacda25fdf473fed3c6db717db1f517db4b5cbddf1ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Ascorbate</topic><topic>Ascorbic Acid - blood</topic><topic>Ascorbic Acid - pharmacology</topic><topic>Blood substitute</topic><topic>Blood Substitutes - therapeutic use</topic><topic>Blood Substitutes - toxicity</topic><topic>Buffers</topic><topic>Drug Carriers - toxicity</topic><topic>Ferric Compounds</topic><topic>Ferryl</topic><topic>Guinea Pigs</topic><topic>Hemoglobin</topic><topic>Hemoglobins - metabolism</topic><topic>Hemoglobins - toxicity</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Oxygen - blood</topic><topic>Oxygen - metabolism</topic><topic>Oxyhemoglobins - therapeutic use</topic><topic>Peroxidase</topic><topic>Peroxidases - blood</topic><topic>Urate</topic><topic>Uric Acid - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cooper, Chris E.</creatorcontrib><creatorcontrib>Silaghi-Dumitrescu, Radu</creatorcontrib><creatorcontrib>Rukengwa, Martine</creatorcontrib><creatorcontrib>Alayash, Abdu I.</creatorcontrib><creatorcontrib>Buehler, Paul W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Biochimica et biophysica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cooper, Chris E.</au><au>Silaghi-Dumitrescu, Radu</au><au>Rukengwa, Martine</au><au>Alayash, Abdu I.</au><au>Buehler, Paul W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peroxidase activity of hemoglobin towards ascorbate and urate: A synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC)</atitle><jtitle>Biochimica et biophysica acta</jtitle><addtitle>Biochim Biophys Acta</addtitle><date>2008-10-01</date><risdate>2008</risdate><volume>1784</volume><issue>10</issue><spage>1415</spage><epage>1420</epage><pages>1415-1420</pages><issn>1570-9639</issn><issn>0006-3002</issn><eissn>1878-1454</eissn><abstract>Acellular hemoglobins developed as oxygen bridging agents with volume expanding properties (“blood substitutes”) are prone to autoxidation and oxidant-mediated structural changes in circulation. In the presence of hydrogen peroxide and either ascorbate or urate we show that ferric hemoglobin functions as a true enzymatic peroxidase. The activity saturates with both substrates and is linearly dependent on protein concentration. The activity is enhanced at low pH with a p K a of 4.7, consistent with protonation of the ferryl species (Fe(IV)−OH) as the active intermediate. To test whether these redox reactions define its behaviour in vivo we exchanged transfused guinea pigs with 50% polymerized bovine Hb (PolyHbBv) and monitored plasma levels of endogenous ascorbate and urate. Immediately after transfusion, met PolyHbBv levels increased up to 30% of total Hb and remained at this level during the first 24 h post transfusion. Plasma ascorbate decreased by 50% whereas urate levels remained unchanged after transfusion. A simple kinetic model, assuming that ascorbate was a more active ferric heme reductase and peroxidase substrate than urate, was consistent with the in vivo data. The present finding confirms the primary and secondary roles of ascorbate and urate respectively in maintaining the oxidative stability of infused Hb.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>18457681</pmid><doi>10.1016/j.bbapap.2008.03.019</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1570-9639
ispartof Biochimica et biophysica acta, 2008-10, Vol.1784 (10), p.1415-1420
issn 1570-9639
0006-3002
1878-1454
language eng
recordid cdi_proquest_miscellaneous_745714533
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Ascorbate
Ascorbic Acid - blood
Ascorbic Acid - pharmacology
Blood substitute
Blood Substitutes - therapeutic use
Blood Substitutes - toxicity
Buffers
Drug Carriers - toxicity
Ferric Compounds
Ferryl
Guinea Pigs
Hemoglobin
Hemoglobins - metabolism
Hemoglobins - toxicity
Humans
Kinetics
Oxygen - blood
Oxygen - metabolism
Oxyhemoglobins - therapeutic use
Peroxidase
Peroxidases - blood
Urate
Uric Acid - blood
title Peroxidase activity of hemoglobin towards ascorbate and urate: A synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A43%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peroxidase%20activity%20of%20hemoglobin%20towards%20ascorbate%20and%20urate:%20A%20synergistic%20protective%20strategy%20against%20toxicity%20of%20Hemoglobin-Based%20Oxygen%20Carriers%20(HBOC)&rft.jtitle=Biochimica%20et%20biophysica%20acta&rft.au=Cooper,%20Chris%20E.&rft.date=2008-10-01&rft.volume=1784&rft.issue=10&rft.spage=1415&rft.epage=1420&rft.pages=1415-1420&rft.issn=1570-9639&rft.eissn=1878-1454&rft_id=info:doi/10.1016/j.bbapap.2008.03.019&rft_dat=%3Cproquest_cross%3E745714533%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=745714533&rft_id=info:pmid/18457681&rft_els_id=S1570963908001039&rfr_iscdi=true